Significant discovery in breast cancer research: Inhibiting collagen XVIII function weakens cancer cells

Researchers at the University of Oulu have made a discovery in breast cancer research. They demonstrated that the extracellular matrix protein collagen XVIII significantly promotes breast cancer progression and metastasis. Additionally, they showed that inhibiting the function of this collagen improves the efficiency of certain commonly used targeted therapies for breast cancer. These findings are significant as they may lead to the development of more effective and entirely new cancer drugs.